X-45089908-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001291415.2(KDM6A):​c.3870T>C​(p.Ala1290Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000803 in 1,206,164 control chromosomes in the GnomAD database, including 6 homozygotes. There are 266 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0043 ( 2 hom., 133 hem., cov: 22)
Exomes 𝑓: 0.00044 ( 4 hom. 133 hem. )

Consequence

KDM6A
NM_001291415.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.218

Publications

0 publications found
Variant links:
Genes affected
KDM6A (HGNC:12637): (lysine demethylase 6A) This gene is located on the X chromosome and is the corresponding locus to a Y-linked gene which encodes a tetratricopeptide repeat (TPR) protein. The encoded protein of this gene contains a JmjC-domain and catalyzes the demethylation of tri/dimethylated histone H3. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2014]
KDM6A Gene-Disease associations (from GenCC):
  • Kabuki syndrome 2
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant X-45089908-T-C is Benign according to our data. Variant chrX-45089908-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 471949.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.218 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00432 (481/111389) while in subpopulation AFR AF = 0.0143 (439/30641). AF 95% confidence interval is 0.0132. There are 2 homozygotes in GnomAd4. There are 133 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High AC in GnomAd4 at 481 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KDM6ANM_001291415.2 linkc.3870T>C p.Ala1290Ala synonymous_variant Exon 26 of 30 ENST00000611820.5 NP_001278344.1 A0A087X0R0B7ZKN5Q86TD1B7ZKN6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KDM6AENST00000611820.5 linkc.3870T>C p.Ala1290Ala synonymous_variant Exon 26 of 30 1 NM_001291415.2 ENSP00000483595.2 A0A087X0R0

Frequencies

GnomAD3 genomes
AF:
0.00432
AC:
481
AN:
111336
Hom.:
2
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0144
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00306
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00604
GnomAD2 exomes
AF:
0.00121
AC:
219
AN:
181691
AF XY:
0.000965
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.000627
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000369
Gnomad OTH exome
AF:
0.000669
GnomAD4 exome
AF:
0.000445
AC:
487
AN:
1094775
Hom.:
4
Cov.:
30
AF XY:
0.000369
AC XY:
133
AN XY:
360281
show subpopulations
African (AFR)
AF:
0.0157
AC:
412
AN:
26325
American (AMR)
AF:
0.000713
AC:
25
AN:
35085
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19344
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30173
South Asian (SAS)
AF:
0.0000371
AC:
2
AN:
53850
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40515
Middle Eastern (MID)
AF:
0.000485
AC:
2
AN:
4126
European-Non Finnish (NFE)
AF:
0.0000119
AC:
10
AN:
839391
Other (OTH)
AF:
0.000783
AC:
36
AN:
45966
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00432
AC:
481
AN:
111389
Hom.:
2
Cov.:
22
AF XY:
0.00396
AC XY:
133
AN XY:
33559
show subpopulations
African (AFR)
AF:
0.0143
AC:
439
AN:
30641
American (AMR)
AF:
0.00305
AC:
32
AN:
10477
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3552
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2592
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5999
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53079
Other (OTH)
AF:
0.00596
AC:
9
AN:
1510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00217
Hom.:
10
Bravo
AF:
0.00491

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 13, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 19, 2019
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KDM6A-related disorder Benign:1
Sep 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Kabuki syndrome 2 Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
7.6
DANN
Benign
0.66
PhyloP100
-0.22
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142238688; hg19: chrX-44949153; COSMIC: COSV104429189; API